Similar articles

• [Theophylline in treatment of bronchial obstructive diseases].

  Rogala B. Rogala B. Wiad Lek. 1998;51(3-4):117-21. Wiad Lek. 1998. PMID: 9658984 Review. Polish.
• Adenosine receptor ligands: potential as therapeutic agents in asthma and COPD.

  Fozard JR, Hannon JP. Fozard JR, et al. Pulm Pharmacol Ther. 1999;12(2):111-4. doi: 10.1006/pupt.1999.0191. Pulm Pharmacol Ther. 1999. PMID: 10373392 Review. No abstract available.
• [Use of bronchodilators in the therapy of obstructive respiratory diseases].

  [No authors listed] [No authors listed] Fortschr Med. 1983 Mar 17;101(10):435-6. Fortschr Med. 1983. PMID: 6840647 German. No abstract available.
• New concepts in bronchodilator therapy.

  Owens GR. Owens GR. Am Fam Physician. 1986 Jan;33(1):218-29. Am Fam Physician. 1986. PMID: 2934965 Review. No abstract available.
• Doxofylline: a new generation xanthine bronchodilator devoid of major cardiovascular adverse effects.

  Dini FL, Cogo R. Dini FL, et al. Curr Med Res Opin. 2001;16(4):258-68. doi: 10.1185/030079901750120196. Curr Med Res Opin. 2001. PMID: 11268710 Review.